razoxane has been researched along with Testicular Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergh, J; Davies, SL; Harris, AL; Hickson, ID | 1 |
1 other study(ies) available for razoxane and Testicular Neoplasms
| Article | Year |
|---|---|
Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Breast Neoplasms; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Neoplasm; Humans; Male; Razoxane; RNA, Messenger; Testicular Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1997 |